tiprankstipranks
Trending News
More News >
Keymed Biosciences, Inc. (HK:2162)
:2162
Hong Kong Market

Keymed Biosciences, Inc. (2162) Cash flow

Compare
1 Followers

Keymed Biosciences, Inc. Cash Flow

HK:2162's free cash flow for Q2 2025 was ¥-330.52M. For the 2025 fiscal year, HK:2162's free cash flow was decreased by ¥-317.90M and operating cash flow was ¥-180.96M. See a summary of the company’s cash flow.
Cash Flow
Dec 24Dec 23Dec 22Dec 21Dec 20
Operating Cash Flow
¥ -789.63M¥ -303.62M¥ -401.93M¥ -214.64M¥ -119.36M
Investing Cash Flow
¥ 67.71M¥ 468.20M¥ -645.59M¥ -2.04B¥ -113.07M
Financing Cash Flow
¥ 283.90M¥ 72.13M¥ -8.06M¥ 3.64B¥ 7.40M
End Cash Position
¥ 418.41M¥ 851.03M¥ 604.07M¥ 1.52B¥ 199.41M
Free Cash Flow
¥ -1.00B¥ -686.23M¥ -681.48M¥ -387.50M¥ -139.26M
Currency in CNY

Keymed Biosciences, Inc. Cash Flow